Cargando…
Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics
The revival of psychedelic research coincided and more recently conjoined with psychopharmacological research on how drugs affect moral judgments and behaviors. This article makes the case for a moral psychopharmacology of psychedelics that examines whether psychedelics serve as non-specific amplifi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365088/ https://www.ncbi.nlm.nih.gov/pubmed/34408677 http://dx.doi.org/10.3389/fpsyt.2021.680064 |
_version_ | 1783738637065650176 |
---|---|
author | Langlitz, Nicolas Dyck, Erika Scheidegger, Milan Repantis, Dimitris |
author_facet | Langlitz, Nicolas Dyck, Erika Scheidegger, Milan Repantis, Dimitris |
author_sort | Langlitz, Nicolas |
collection | PubMed |
description | The revival of psychedelic research coincided and more recently conjoined with psychopharmacological research on how drugs affect moral judgments and behaviors. This article makes the case for a moral psychopharmacology of psychedelics that examines whether psychedelics serve as non-specific amplifiers that enable subjects to (re-)connect with their values, or whether they promote specific moral-political orientations such as liberal and anti-authoritarian views, as recent psychopharmacological studies suggest. This question gains urgency from the fact that the return of psychedelics from counterculture and underground laboratories to mainstream science and society has been accompanied by a diversification of their users and uses. We propose bringing the pharmacological and neuroscientific literature into a conversation with historical and anthropological scholarship documenting the full spectrum of moral and political views associated with the uses of psychedelics. This paper sheds new light on the cultural plasticity of drug action and has implications for the design of psychedelic pharmacopsychotherapies. It also raises the question of whether other classes of psychoactive drugs have an equally rich moral and political life. |
format | Online Article Text |
id | pubmed-8365088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83650882021-08-17 Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics Langlitz, Nicolas Dyck, Erika Scheidegger, Milan Repantis, Dimitris Front Psychiatry Psychiatry The revival of psychedelic research coincided and more recently conjoined with psychopharmacological research on how drugs affect moral judgments and behaviors. This article makes the case for a moral psychopharmacology of psychedelics that examines whether psychedelics serve as non-specific amplifiers that enable subjects to (re-)connect with their values, or whether they promote specific moral-political orientations such as liberal and anti-authoritarian views, as recent psychopharmacological studies suggest. This question gains urgency from the fact that the return of psychedelics from counterculture and underground laboratories to mainstream science and society has been accompanied by a diversification of their users and uses. We propose bringing the pharmacological and neuroscientific literature into a conversation with historical and anthropological scholarship documenting the full spectrum of moral and political views associated with the uses of psychedelics. This paper sheds new light on the cultural plasticity of drug action and has implications for the design of psychedelic pharmacopsychotherapies. It also raises the question of whether other classes of psychoactive drugs have an equally rich moral and political life. Frontiers Media S.A. 2021-08-02 /pmc/articles/PMC8365088/ /pubmed/34408677 http://dx.doi.org/10.3389/fpsyt.2021.680064 Text en Copyright © 2021 Langlitz, Dyck, Scheidegger and Repantis. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Langlitz, Nicolas Dyck, Erika Scheidegger, Milan Repantis, Dimitris Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics |
title | Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics |
title_full | Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics |
title_fullStr | Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics |
title_full_unstemmed | Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics |
title_short | Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics |
title_sort | moral psychopharmacology needs moral inquiry: the case of psychedelics |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365088/ https://www.ncbi.nlm.nih.gov/pubmed/34408677 http://dx.doi.org/10.3389/fpsyt.2021.680064 |
work_keys_str_mv | AT langlitznicolas moralpsychopharmacologyneedsmoralinquirythecaseofpsychedelics AT dyckerika moralpsychopharmacologyneedsmoralinquirythecaseofpsychedelics AT scheideggermilan moralpsychopharmacologyneedsmoralinquirythecaseofpsychedelics AT repantisdimitris moralpsychopharmacologyneedsmoralinquirythecaseofpsychedelics |